[HTML][HTML] CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands

J Korbecki, S Grochans, I Gutowska, K Barczak… - International journal of …, 2020 - mdpi.com
CC chemokines (or β-chemokines) are 28 chemotactic cytokines with an N-terminal CC
domain that play an important role in immune system cells, such as CD4+ and CD8+ …

[HTML][HTML] S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T …

Y Nagira, M Nagira, R Nagai, W Nogami, M Hirata… - Molecular Cancer …, 2023 - AACR
Although regulatory T cells (Treg) are inhibitory immune cells that are essential for
maintaining immune homeostasis, Tregs that infiltrate tumor tissue promote tumor growth by …

High expression of CC chemokine receptor 5 (CCR5) promotes disease progression in patients with B-cell non-Hodgkin lymphomas

A Butrym, I Kryczek, D Dlubek, E Jaskula… - Current Problems in …, 2018 - Elsevier
Chemokines are small proteins, that regulate cell migration in many physiological and
pathologic processes in human body. They are also responsible for cancer progression. CC …

Anti-CCR5 antibody

WC Olson, PJ Maddon, N Tsurushita… - US Patent …, 2010 - Google Patents
The invention is directed an anti-CCR5 antibody which com prises (i) two light chains, each
light chain comprising the expression product of a plasmid designated pVK: HuPRO14O-VK …

Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor‐induced immunosuppression

YM Yang, AL Feng, CJ Zhou, XH Liang… - Cancer …, 2011 - Wiley Online Library
The chemokine receptor CCR4 is preferentially expressed on certain immune cells and
some hematological tumor cells, which play pivotal roles in suppression of host immune …

A role for CCL2 in both tumor progression and immunosurveillance

M Li, DA Knight, LA Snyder, MJ Smyth… - …, 2013 - Taylor & Francis
The chemokine CCL2, which is best known for its chemotactic functions, is expressed not
only by immune cells, but also by several types of malignant and stromal cells. CCL2 has …

Immunotherapy of B‐cell non‐Hodgkin lymphoma by targeting the chemokine receptor CXCR5 in a preclinical mouse model

H Panjideh, G Müller, M Koch, F Wilde… - … journal of cancer, 2014 - Wiley Online Library
Bispecific antibodies are promising agents for immunotherapy. Here, we describe a
quadroma‐based trifunctional bispecific antibody binding the chemokine receptor CXCR5 …

[HTML][HTML] CCR6 as a potential target for therapeutic antibodies for the treatment of inflammatory diseases

S Gómez-Melero, J Caballero-Villarraso - Antibodies, 2023 - mdpi.com
The CC chemokine receptor 6 (CCR6) is a G protein-coupled receptor (GPCR) involved in a
wide range of biological processes. When CCR6 binds to its sole ligand CCL20, a signaling …

The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice

RP Gladue, SH Cole, ML Roach… - The Journal of …, 2006 - journals.aai.org
We previously described the in vitro characteristics of the potent and selective CCR1
antagonist, CP-481,715. In addition to being selective for CCR1 vs other chemokine …

CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomas

SJ Rodig, D Jones, A Shahsafaei, DM Dorfman - Human pathology, 2002 - Elsevier
Several recent studies have revealed important contributions of chemokines and their
receptors to the development and progression of both hematopoietic and nonhematopoietic …